Board Member
Tg Therapeutics, Inc. (TGTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Tg Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TGTX alertsMichael S. Weiss is recorded as Board Member at Tg Therapeutics, Inc. (TGTX) since January 1, 2011 and CEO at Tg Therapeutics, Inc. (TGTX). The newest filing on record that lists Michael S. Weiss as CEO at Tg Therapeutics, Inc. (TGTX) is dated April 30, 2026. The newest filing on record that lists Michael S. Weiss as Board Member at Tg Therapeutics, Inc. (TGTX) is dated May 1, 2023. Tg Therapeutics, Inc. reported in an 8-K filed June 17, 2024 that Michael S. Weiss was appointed Director, effective June 14, 2024. The proxy statement of Tg Therapeutics, Inc. reports total compensation of $42,666,831 for Michael S. Weiss in fiscal 2021, including a base salary of $1,289,985. Disclosed compensation is on record for 5 fiscal years. Michael S. Weiss has spoken on 1 earnings call across 1 company, most recently for Tg Therapeutics, Inc. on August 3, 2026. Tg Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tg Therapeutics, Inc. includes Sean A. Power (CFO), Daniel Hume (Board Member), Dr. Sagar Lonial (Board Member) and 6 others.
“The votes with respect to the election of the six directors to hold office until the 2025 annual meeting were as follows: Michael S. Weiss 57,264,472 75.23% 18,849,954 24.77% 34,960,603”
“The second quarter of 2026 was another quarter of strong execution. More importantly, it marked an important evolution for TG Therapeutics. For the last several years, we've been fingerly focused on one objective, establishing pre-omphi as a leading therapy in relapsing multiple sclerosis.”
2011-01-01–present
Last confirmed May 1, 2023
Start not stated–present
Last confirmed April 30, 2026
Biotechnology · Healthcare
CEO, Board Member
2011-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Tg Therapeutics, Inc. (TGTX) | Chief Executive Officer and President | $1,289,985 | $42,666,831 |
| 2020 | Tg Therapeutics, Inc. (TGTX) | Chief Executive Officer and President | $1,392,470 | $32,497,238 |
| 2019 | Tg Therapeutics, Inc. (TGTX) | Chief Executive Officer and President | $636,500 | $12,674,726 |
| 2018 | Tg Therapeutics, Inc. (TGTX) | Chief Executive Officer and President | $655,625 | $14,298,771 |
| 2017 | Tg Therapeutics, Inc. (TGTX) | Chief Executive Officer and President — | $525,000 | $9,926,616 |
